AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Olfactory and Brain Stimulations in Treatment-resistant Depression

RecruitingNAAges 18 Years - anyAllHôpital le Vinatier
💬

In plain words

What the trial is, and whether it could suit you

This is a prospective, randomized, double-blind, parallel-group controlled trial. The aim of this research project is to compare the clinical benefits achieved in patients with major depressive disorder (MDD) following two types of intervention: iTBS active alone or iTBS active combined with olfactory stimulations.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * had a primary diagnosis of single-episode or recurrent non-psychotic major depressive disorder according to Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) criteria; * scored 20 or over on the MADRS (Montgomery-Åsberg Depression Rating Scale) (Montgomery and Åsberg, 1979) and scored higher than 2 on the MADRS item 8 anhedonia factor score; * a stable antidepressant medication for 4 weeks prior to inclusion; be able to speak and read French; * sign a consent form before intervention. Exclusion Criteria: * a pre-existing condition that affects olfaction including congenital anosmia, upper respiratory tract infection, nasal and/or sinus disease, brain injury or nasal surgery; a neurological disease; * other comorbid psychiatric disorders or substance abuse (except tobacco); * contraindications to TMS (medical devices implanted or metallic foreign body in the head); * pregnant or lactating mothers (controlled by urine pregnancy tests); * measure of protection or guardianship of justice.
💊

What it tests

  • Non-invasive brain stimulation protocol (intermittent theta burst protocol (iTBS)) combined with pleasant odors delivered during the iTBS procol.
  • Non-invasive brain stimulation protocol (intermittent theta burst protocol (iTBS)) delivered alone.
📍

Where

1 site
CH Le Vinatier
Bron, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy